Form 4: AIM ImmunoTech Officer Acquires Shares in Recent Transaction
SEC Form 4 Filing
Peter W. Rodino III, COO, Secretary, and General Counsel of AIM ImmunoTech Inc., acquired 30,865 shares of common stock at $0.405 per share on May 6, 2024.
Summary
- On May 6, 2024, Peter W. Rodino III, the COO, Secretary, and General Counsel of AIM ImmunoTech Inc., purchased 30,865 shares of the company's common stock.
- The shares were acquired at a price of $0.405 per share.
- Following the transaction, Rodino directly owns 212,583 shares of AIM ImmunoTech Inc.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. An officer buying shares suggests confidence, but it's a single transaction and doesn't provide a comprehensive view of the company's health.
Positives
- The purchase of shares by a company officer can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Insider trading activity is closely monitored by regulators and investors as it can provide insights into a company's performance and future prospects. Form 4 filings are a routine part of this monitoring process.
Stakeholder Impact
- The share purchase by a company officer may positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/06/2024 | Date of the transaction where Peter W. Rodino III acquired shares of AIM ImmunoTech Inc. |
| 05/07/2024 | Date of signature for the Form 4 filing. |
Keywords
AIM ImmunoTech Inc., insider trading, Form 4, share acquisition, Peter W. Rodino III, common stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.